These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 9849450

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.
    Clemons MJ, Marshall E, Dürig J, Watanabe K, Howell A, Miles D, Earl H, Kiernan J, Griffiths A, Towlson K, DeTakats P, Testa NG, Dougal M, Hunter MG, Wood LM, Czaplewski LG, Millar A, Dexter TM, Lord BI.
    Blood; 1998 Sep 01; 92(5):1532-40. PubMed ID: 9716580
    [Abstract] [Full Text] [Related]

  • 3. A randomized phase II study of BB-10010: a variant of human macrophage inflammatory protein-1alpha for patients receiving high-dose etoposide and cyclophosphamide for malignant lymphoma and breast cancer.
    Bernstein SH, Eaves CJ, Herzig R, Fay J, Lynch J, Phillips GL, Christiansen N, Reece D, Ericson S, Stephan M, Kovalsky M, Hawkins K, Rasmussen H, Devos A, Herzig GP.
    Br J Haematol; 1997 Dec 01; 99(4):888-95. PubMed ID: 9432038
    [Abstract] [Full Text] [Related]

  • 4. BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties.
    Hunter MG, Bawden L, Brotherton D, Craig S, Cribbes S, Czaplewski LG, Dexter TM, Drummond AH, Gearing AH, Heyworth CM, Lord BI, McCourt M, Varley PG, Wood LM, Edwards RM, Lewis PJ.
    Blood; 1995 Dec 15; 86(12):4400-8. PubMed ID: 8541527
    [Abstract] [Full Text] [Related]

  • 5. Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.
    Marshall E, Woolford LB, Lord BI.
    Br J Cancer; 1997 Dec 15; 75(12):1715-20. PubMed ID: 9192972
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer.
    Broxmeyer HE, Orazi A, Hague NL, Sledge GW, Rasmussen H, Gordon MS.
    Blood Cells Mol Dis; 1998 Mar 15; 24(1):14-30. PubMed ID: 9516378
    [Abstract] [Full Text] [Related]

  • 8. The effects of human macrophage inflammatory protein-1 alpha and its genetically modified variant, BB10010, on phagocyte function.
    Williams SL, Addison IE, Mollapour E, Czaplewski LG, Linch DC, Roberts PJ.
    Cytokines Cell Mol Ther; 1997 Mar 15; 3(1):41-50. PubMed ID: 9287243
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
    Cooper S, Mantel C, Broxmeyer HE.
    Exp Hematol; 1994 Feb 15; 22(2):186-93. PubMed ID: 8299739
    [Abstract] [Full Text] [Related]

  • 11. Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice.
    Gilmore GL, DePasquale DK, Shadduck RK.
    Exp Hematol; 1999 Feb 15; 27(2):195-202. PubMed ID: 10029156
    [Abstract] [Full Text] [Related]

  • 12. Abl protein kinase abrogates the response of multipotent haemopoietic cells to the growth inhibitor macrophage inflammatory protein-1 alpha.
    Wark G, Heyworth CM, Spooncer E, Czaplewski L, Francis JM, Dexter TM, Whetton AD.
    Oncogene; 1998 Mar 12; 16(10):1319-24. PubMed ID: 9546433
    [Abstract] [Full Text] [Related]

  • 13. Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols.
    Arango D, Ettarh RR, Brennan PC.
    Dig Dis Sci; 2000 Dec 12; 45(12):2306-12. PubMed ID: 11258549
    [Abstract] [Full Text] [Related]

  • 14. BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts.
    Arango D, Ettarh RR, Brennan PC.
    Scand J Gastroenterol; 1999 Jan 12; 34(1):68-72. PubMed ID: 10048735
    [Abstract] [Full Text] [Related]

  • 15. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ, Maher D, O'Connor M, Green M, Sheridan W, Rallings M, Bonnem E, Burgess AW, McGrath K, Fox RM.
    Cancer Res; 1990 Feb 01; 50(3):606-14. PubMed ID: 2404573
    [Abstract] [Full Text] [Related]

  • 16. Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: its role in regulation of hematopoiesis and osteoclast recruitment.
    Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T, Sugioka Y, Miura R, Iijima T.
    Lab Invest; 1997 Mar 01; 76(3):399-406. PubMed ID: 9121122
    [Abstract] [Full Text] [Related]

  • 17. A phase II protection study of BB-10010 in patients with high grade non-Hodgkin's lymphoma undergoing intensive chemotherapy.
    Hough RE, Lorigan PC, Poynton C, Newland A, Gupta RK, Foran J, Hancock BW.
    Int J Oncol; 2003 Feb 01; 22(2):421-4. PubMed ID: 12527943
    [Abstract] [Full Text] [Related]

  • 18. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
    Pender SL, Chance V, Whiting CV, Buckley M, Edwards M, Pettipher R, MacDonald TT.
    Gut; 2005 Aug 01; 54(8):1114-20. PubMed ID: 16009684
    [Abstract] [Full Text] [Related]

  • 19. A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
    Prendiville J, Crowther D, Thatcher N, Woll PJ, Fox BW, McGown A, Testa N, Stern P, McDermott R, Potter M.
    Br J Cancer; 1993 Aug 01; 68(2):418-24. PubMed ID: 8347500
    [Abstract] [Full Text] [Related]

  • 20. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes.
    Lee SC, Brummet ME, Shahabuddin S, Woodworth TG, Georas SN, Leiferman KM, Gilman SC, Stellato C, Gladue RP, Schleimer RP, Beck LA.
    J Immunol; 2000 Mar 15; 164(6):3392-401. PubMed ID: 10706735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.